Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus

‘What’s in a name? That which we call a rose/By any other name would smell as sweet’ (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare’s implication is that a name is nothing but a word, and it therefore represents a convention with no intrinsic meaning. While this may be relevant...

Full description

Bibliographic Details
Main Authors: Hiroshi Arima, Timothy Cheetham, Mirjam Christ-Crain, Deborah Cooper, Mark Gurnell, Juliana B Drummond, Miles Levy, Ann I McCormack, Joseph Verbalis, John Newell-Price, John A H Wass
Format: Article
Language:English
Published: Bioscientifica 2022-10-01
Series:Endocrine Connections
Subjects:
Online Access:https://ec.bioscientifica.com/view/journals/ec/11/11/EC-22-0378.xml
_version_ 1811229944831803392
author Hiroshi Arima
Timothy Cheetham
Mirjam Christ-Crain
Deborah Cooper
Mark Gurnell
Juliana B Drummond
Miles Levy
Ann I McCormack
Joseph Verbalis
John Newell-Price
John A H Wass
author_facet Hiroshi Arima
Timothy Cheetham
Mirjam Christ-Crain
Deborah Cooper
Mark Gurnell
Juliana B Drummond
Miles Levy
Ann I McCormack
Joseph Verbalis
John Newell-Price
John A H Wass
author_sort Hiroshi Arima
collection DOAJ
description ‘What’s in a name? That which we call a rose/By any other name would smell as sweet’ (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare’s implication is that a name is nothing but a word, and it therefore represents a convention with no intrinsic meaning. While this may be relevant to romantic literature, disease names do have real meanings, and consequences, in medicine. Hence, there must be a very good rationale for changing the name of a disease that has a centuries-old historical context. A working group of representatives from national and international endocrinology, and pediatric endocrine societies now proposes changing the name of ‘diabetes insipidus’ to ‘arginine vasopressin deficiency (AVP-D)’ for central etiologies, and ‘arginine vasopr essin resistance (AVP-R)’ for nephrogenic etiologies. This article provides both the historical context and the rationale for this proposed name change.
first_indexed 2024-04-12T10:21:42Z
format Article
id doaj.art-a0532482c3394a2caccb512e87e17c8f
institution Directory Open Access Journal
issn 2049-3614
language English
last_indexed 2024-04-12T10:21:42Z
publishDate 2022-10-01
publisher Bioscientifica
record_format Article
series Endocrine Connections
spelling doaj.art-a0532482c3394a2caccb512e87e17c8f2022-12-22T03:37:05ZengBioscientificaEndocrine Connections2049-36142022-10-01111114https://doi.org/10.1530/EC-22-0378Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes InsipidusHiroshi Arima0Timothy Cheetham1Mirjam Christ-Crain2Deborah Cooper3Mark Gurnell4Juliana B Drummond5Miles Levy6Ann I McCormack7Joseph Verbalis8John Newell-Price9John A H Wass10Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan; Japanese Endocrine Society Department of Paediatric Endocrinology, Newcastle University Faculty of Medical Sciences, Great North Children’s Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, UK; European Society for Pediatric EndocrinologyDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Basel, University of Basel, Switzerland; European Society of EndocrinologyPituitary Foundation, Bristol, UKEuropean Society of Endocrinology; Wellcome-MRC Institute of Metabolic Science, University of Cambridge & Addenbrooke’s Hospital, Cambridge Biomedical Campus, Cambridge, UKFaculdade de Medicina da UFMG, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Brazilian Society of Endocrinology and Metabolism Endocrinology, University Hospitals of Leicester, Leicester, UK; Society for EndocrinologyHormones and Cancer Group, Garvan Institute of Medical Research, Sydney, New South Wales, Australia; Endocrine Society of Australia Endocrinology and Metabolism, Georgetown University Medical Center, Washington DC, District of Columbia, USA; Endocrine Society Endocrine Society; Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, UKDepartment of Endocrinology, Oxford Centre for Diabetes Endocrinology & Metabolism – Endocrinology, Oxford, UK; Pituitary Society ‘What’s in a name? That which we call a rose/By any other name would smell as sweet’ (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare’s implication is that a name is nothing but a word, and it therefore represents a convention with no intrinsic meaning. While this may be relevant to romantic literature, disease names do have real meanings, and consequences, in medicine. Hence, there must be a very good rationale for changing the name of a disease that has a centuries-old historical context. A working group of representatives from national and international endocrinology, and pediatric endocrine societies now proposes changing the name of ‘diabetes insipidus’ to ‘arginine vasopressin deficiency (AVP-D)’ for central etiologies, and ‘arginine vasopr essin resistance (AVP-R)’ for nephrogenic etiologies. This article provides both the historical context and the rationale for this proposed name change.https://ec.bioscientifica.com/view/journals/ec/11/11/EC-22-0378.xmlrenamingdiabetes insipidus
spellingShingle Hiroshi Arima
Timothy Cheetham
Mirjam Christ-Crain
Deborah Cooper
Mark Gurnell
Juliana B Drummond
Miles Levy
Ann I McCormack
Joseph Verbalis
John Newell-Price
John A H Wass
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus
Endocrine Connections
renaming
diabetes insipidus
title Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus
title_full Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus
title_fullStr Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus
title_full_unstemmed Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus
title_short Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus
title_sort changing the name of diabetes insipidus a position statement of the working group for renaming diabetes insipidus
topic renaming
diabetes insipidus
url https://ec.bioscientifica.com/view/journals/ec/11/11/EC-22-0378.xml
work_keys_str_mv AT hiroshiarima changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus
AT timothycheetham changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus
AT mirjamchristcrain changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus
AT deborahcooper changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus
AT markgurnell changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus
AT julianabdrummond changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus
AT mileslevy changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus
AT annimccormack changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus
AT josephverbalis changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus
AT johnnewellprice changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus
AT johnahwass changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus